Adverse events associated with dupilumab in the World Health Organization pharmacovigilance database
Author:
Publisher
Elsevier BV
Subject
Dermatology
Reference5 articles.
1. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis;Simpson;N Engl J Med,2016
2. Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort;Faiz;J Am Acad Dermatol,2019
3. Appraisal of the MedDRA conceptual structure for describing and grouping adverse drug reactions;Bousquet;Drug Saf,2005
4. A Bayesian neural network method for adverse drug reaction signal generation;Bate;Eur J Clin Pharmacol,1998
5. Progression of cutaneous T-cell lymphoma after dupilumab: case review of 7 patients;Espinosa;J Am Acad Dermatol,2020
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Interactions between dupilumab and vitiligo: A scoping review;Journal of the European Academy of Dermatology and Venereology;2024-08-06
2. Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database;BioDrugs;2024-03-15
3. Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK Inhibitors;American Journal of Clinical Dermatology;2024-01-12
4. A case of leukocytoclastic vasculitis in a patient on dupilumab;JAAD Case Reports;2023-12
5. Parasitic infections related to anti-type 2 immunity monoclonal antibodies: a disproportionality analysis in the food and drug administration’s adverse event reporting system (FAERS);Frontiers in Pharmacology;2023-11-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3